OMNIAB, INC. Earnings Per Share (Basic)
OMNIAB, INC. (OABI) reported Earnings Per Share (Basic) of -$0.05 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- OMNIAB, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.05.
- OMNIAB, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.06.
- OMNIAB, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.11.
- OMNIAB, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.14.
- OMNIAB, INC. earnings per share, basic for fiscal 2025 was -$0.57.
- OMNIAB, INC. earnings per share, basic for fiscal 2024 was -$0.61.
- OMNIAB, INC. earnings per share, basic for fiscal 2023 was -$0.51.
- OMNIAB, INC. earnings per share, basic for fiscal 2022 was -$0.26.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 8 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.05 10-Q · filed 2026-08-06 | -$0.11 10-Q · filed 2026-08-06 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2026-03-31 | -$0.06 10-Q · filed 2026-05-07 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2025-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.57 10-K · filed 2026-03-04 | |
| 2025-09-30 | -$0.14 10-Q · filed 2025-11-04 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.46 10-Q · filed 2025-11-04 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2025-06-30 | -$0.15 10-Q · filed 2026-08-06 | -$0.32 10-Q · filed 2026-08-06 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2025-03-31 | -$0.17 10-Q · filed 2026-05-07 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-08-06 | |
| 2024-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$0.61 10-K · filed 2026-03-04 | |
| 2024-09-30 | -$0.16 10-Q · filed 2025-11-04 | -$0.29 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$0.48 10-Q · filed 2025-11-04 | -$0.62 derived: net income ÷ weighted average shares · filed 2025-11-04 | |
| 2024-06-30 | -$0.13 10-Q · filed 2025-08-06 | -$0.32 10-Q · filed 2025-08-06 | -$0.46 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$0.62 derived: net income ÷ weighted average shares · filed 2025-11-04 | |
| 2024-03-31 | -$0.19 10-Q · filed 2025-05-08 | -$0.33 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$0.49 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$0.63 derived: net income ÷ weighted average shares · filed 2025-11-04 | |
| 2023-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2025-03-18 | -$0.30 derived: net income ÷ weighted average shares · filed 2025-03-18 | -$0.45 derived: net income ÷ weighted average shares · filed 2025-03-18 | -$0.51 10-K · filed 2025-03-18 | |
| 2023-09-30 | -$0.16 10-Q · filed 2024-11-12 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.37 10-Q · filed 2024-11-12 | -$0.30 derived: net income ÷ weighted average shares · filed 2024-11-12 | |
| 2023-06-30 | -$0.15 10-Q · filed 2024-08-08 | -$0.21 10-Q · filed 2024-08-08 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.28 derived: net income ÷ weighted average shares · filed 2024-11-12 | |
| 2023-03-31 | -$0.06 10-Q · filed 2024-05-09 | $0.01 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.13 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.25 derived: net income ÷ weighted average shares · filed 2024-11-12 | |
| 2022-12-31 | $0.07 derived: net income ÷ weighted average shares · filed 2024-03-25 | -$0.07 derived: net income ÷ weighted average shares · filed 2024-03-25 | -$0.19 derived: net income ÷ weighted average shares · filed 2024-03-25 | -$0.26 10-K · filed 2024-03-25 | |
| 2022-09-30 | -$0.15 10-Q · filed 2023-11-09 | -$0.28 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$0.35 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$0.12 10-Q · filed 2023-08-10 | -$0.20 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | -$0.08 10-Q · filed 2023-05-11 | ||||
| 2021-12-31 | -$0.33 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$0.01 10-Q · filed 2021-11-10 | -$0.02 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |